Skip to main content
Clinical Trials/NCT00849407
NCT00849407
Unknown
Not Applicable

Genetic Risk Factors and Acquired Oncogenic Mutations of Melanoma

Medical University of Vienna1 site in 1 country2,000 target enrollmentOctober 2008
ConditionsMelanoma

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Melanoma
Sponsor
Medical University of Vienna
Enrollment
2000
Locations
1
Primary Endpoint
melanoma
Last Updated
7 years ago

Overview

Brief Summary

Though it is generally accepted that exposure to sunlight is a major causative factor for skin cancer, the risk for developing melanoma is not directly linked to sun exposure such as in non-melanoma skin cancer. Therefore, a dual pathway has been proposed, distinguishing melanoma that develops on skin that is chronically exposed to sunlight from those that occur on skin that is normally protected. The risk for each type of melanoma is believed to be determined in part by genetic factors. To define these markers reproducibly, the investigators plan to establish a large cohort with comprehensive information regarding sun sensitivity (skin type), history of experienced sun exposure, skin pigmentation phenotypes, total number of nevi, and other types of skin tumors in a central European population. The investigators will obtain blood from all participants for DNA as well as serum analyses. Based on the finding that genetic variants of the melanocortin-1 receptor (MC1R) gene, associated with red hair and fair skin, have been shown to be associated with increased risk for melanoma, particularly those harboring BRAF mutations, the investigators will now focus on the study of recently discovered genetic variants associated with pigmentation. Furthermore, the investigators will study the relation of these variants with oncogenic mutations of melanoma in BRAF, RAS and c-Kit. The study of other genetic variants will follow, once a sufficiently large cohort has been established to reveal an independent genetic risk factor in a multivariate analysis including potential covariates as mentioned above. The identification of genetic risk factors for melanoma will not only help identify individuals with increased risk but also improve our understanding of the molecular background of the development of melanoma.

Registry
clinicaltrials.gov
Start Date
October 2008
End Date
December 2020
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ichiro Okamoto

associate professor

Medical University of Vienna

Eligibility Criteria

Inclusion Criteria

  • patients with or without melanoma

Exclusion Criteria

  • HIV and Hepatitis C positive individuals.

Outcomes

Primary Outcomes

melanoma

Time Frame: 2 years

Secondary Outcomes

  • survival(10 years)

Study Sites (1)

Loading locations...

Similar Trials